Rallybio Corporation (RLYB) Earnings History
Net Loss7 years of earnings data (2019–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Rallybio Corporation (RLYB) Earnings Overview
As of June 29, 2026, Rallybio Corporation (RLYB) reported trailing twelve-month net income of -$8M, reflecting +85.1% year-over-year growth. The company earned $-1.37 per diluted share over the past four quarters, with a net profit margin of -1046.4%.
Looking at the long-term picture, RLYB's historical earnings data spans multiple years. The company achieved its highest annual net income of -$9M in fiscal 2025, representing a new all-time high.
Rallybio Corporation is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including IMVT (-$506M net income), PRAX (-$327M net income), KYMR (-$315M net income, -794.4% margin), RLYB has comparable earnings metrics. Compare RLYB vs IMVT →
RLYB Earnings vs Peers
Earnings metrics vs comparable public companies
RLYB Historical Earnings Data (2019–2025)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$9M | +84.5% | -$28M | $-1.59 | -1046.4% | -3270.9% |
| 2024 | -$58M | +22.5% | -$60M | $-10.64 | -9084.1% | -9511.9% |
| 2023 | -$75M | -11.9% | -$79M | $-14.72 | - | - |
| 2022 | -$67M | -41.8% | -$68M | $-16.72 | - | - |
| 2021 | -$47M | -77.8% | -$46M | $-11.68 | - | - |
| 2020 | -$26M | -50.0% | -$25M | $-9.52 | - | - |
| 2019 | -$18M | - | -$18M | $-6.32 | - | - |
Download Data
Export RLYB earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
7+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
RLYB — Frequently Asked Questions
Quick answers to the most common questions about buying RLYB stock.
What is RLYB earnings per share (EPS)?
RLYB trailing twelve-month (TTM) diluted EPS is $-1.37, reflecting +85.1% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2019 to 2025 is available in the table on this page.
What is Rallybio Corporation's net income?
Rallybio Corporation (RLYB) trailing twelve-month net income is $-8M as of 2025. Earnings grew +85.1% year-over-year.
Is RLYB profitable?
RLYB is not currently profitable on a TTM basis, reporting a net loss of $-8M. Net margin is -1046.4%. Investors should monitor for a return to profitability.
What is RLYB's earnings growth rate?
RLYB compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2019 to 2025.
What are RLYB's profit margins?
Rallybio Corporation net profit margin is -1046.4%, operating margin is -3270.9%, and gross margin is +89.3%. Below-average margins reflect competitive or cost pressures. Return on Equity is -15.0%.
Is RLYB growing earnings?
Yes, RLYB earnings are accelerating — EPS growth of +85.1% exceeds the 5-year CAGR of N/A. TTM net income reached $-8M. Earnings momentum is strengthening.
What was RLYB's best earnings year?
Rallybio Corporation's highest annual net income on record is $-9M, achieved in fiscal year 2025. Earnings history on this page spans 2019 to 2025 and includes all annual and quarterly figures.
What were RLYB's earnings last quarter?
RLYB's most recent reported quarter was Q1 2026. Net income was $-8M with diluted EPS of $-1.46. For a full breakdown of all quarters, see the quarterly earnings table on this page.